Vir Biotechnology (VIR) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 26, 2026, to be held virtually for shareholder participation.

• Shareholders are encouraged to review proxy materials and vote by May 25, 2026, 11:59 PM ET.

Voting matters and shareholder proposals

• Election of three directors: Robert More, Janet Napolitano, and Elliott Sigal, each to serve until the 2029 annual meeting.

• Advisory vote to approve compensation of named executive officers.

• Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.

• Board recommends voting in favor of all proposals.

Board of directors and corporate governance

• Three director nominees presented for election, each with specified professional credentials.

• Directors to serve three-year terms, subject to earlier death, resignation, or removal.